Evaluation of the Effects of Treatment With Bioarginin C in Adult Subjects Belonging to the Post-Covid Day Hospital

Inflammation Clinical Trial

— BC  

Official title:

Evaluation of the Effects of Treatment With Bioarginin C on Physical Exhaustion , Systemic Inflammatory State and Endothelial Function in Adult Subjects Belonging to the Post-Covid Day Hospital

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04947488
• Other study ID #: Bioarginina C
• Status: Recruiting
• Phase: N/A
• Start date: June 18, 2021
• Est. completion date: November 18, 2022

Study information

• Verified date: May 2022
• Source: University of Milan
• Contact: barbara maglione
• Phone: +393343293357
• Email: barbara.maglione[@]farmadamor.it
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Long Covid could be much more frequent than it is thought to be. Few dwell on the great problem represented by the post covid syndrome. The virus often leaves important marks on our body, and those who recover face problems of various kinds: chronic fatigue, shortness of breath, dry cough, headache, cognitive difficulties. On the duration and resolution of this syndrome, now recognized as a highly debilitating condition, there are still no great answers: for this reason it is always important to emphasize that contracting Covid, even in a not serious form, still means exposing oneself to long-term risks that are still not well codified by the scientific community. Guidelines and more tools are expected to best assist these patients.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 50
• Est. completion date: November 18, 2022
• Est. primary completion date: September 18, 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 20 Years to 60 Years

Eligibility

Inclusion Criteria:

subjects with proven positivity to the molecular test for Sars-cov2 with demonstration of microbiological healing patients discharged from FPG or other hospital structures; or only contact in PS; or home management age: range 20-60 years Fatigue operationalized as an affirmative answer to item "7" (CES-D) Exclusion Criteria: Pharmacological therapies with possible interactions with the mechanisms / processes under study (e.g. antihypertensive drugs, cortisone drugs, NSAIDs, immunosuppressants, nitrates)

Related Conditions & MeSH terms

• Fatigue Syndrome, Chronic
• Inflammation

Intervention

Dietary Supplement:
• Bioarginina C
Dietary supplement vials

Locations

Country	Name	City	State
Italy	Barbara Maglione	Napoli

Sponsors (1)

Lead Sponsor	Collaborator
University of Milan

Country where clinical trial is conducted

Italy, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	6 minute walking test to evaluate Fatigue	Effect of Bioarginina C on the prolonged fatigue	30 days